OneAscent Family Office’s Gilead Sciences GILD Stock Holding History

OneAscent Family Office’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$646K	Sell	4,633 -74	-2%	-$10.4K	0.45%	51
2025 Q4	$578K	Buy	4,707 +442	+10%	+$53.7K	0.39%	62
2025 Q3	$473K	Sell	4,265 -87	-2%	-$9.89K	0.39%	68
2025 Q2	$483K	Sell	4,352 -4,632	-52%	-$493K	0.46%	52
2025 Q1	$1.01M	Buy	8,984 +3,871	+76%	+$399K	0.94%	22
2024 Q4	$472K	Buy	+5,113	New	+$460K	0.86%	24

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

OneAscent Family Office's GILD Position: Q1 2026 in Review

OneAscent Family Office reduced its Gilead Sciences (GILD) stake by 1.6% in Q1 2026, selling an estimated $10.4K and leaving 4,633 shares worth $646K. The position accounts for 0.45% of the portfolio, ranked #51.

OneAscent Family Office first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.01M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

OneAscent Family Office held 4,633 shares of Gilead Sciences worth $646K as of Q1 2026.
OneAscent Family Office sold 74 Gilead Sciences shares in Q1 2026, an estimated $10.4K.
Gilead Sciences made up 0.45% of OneAscent Family Office's portfolio in Q1 2026, its #51 holding.
OneAscent Family Office first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
OneAscent Family Office's Gilead Sciences position peaked at $1.01M in Q1 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on OneAscent Family Office's 13F filing for Q1 2026, filed 21 Apr 2026.